Literature DB >> 31129171

Metabolic pathways regulating colorectal cancer initiation and progression.

Sofia La Vecchia1, Carlos Sebastián2.   

Abstract

Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Despite recent advances in the molecular genetics of CRC, poor treatment outcomes highlight the need for a better understanding of the underlying mechanisms accounting for tumor initiation and progression. Recently, deregulation of cellular metabolism has emerged as a key hallmark of cancer. Reprogramming of core cellular metabolic pathways by cancer cells provides energy, anaplerotic precursors and reducing equivalents required to support tumor growth. Here, we review key findings implicating cancer metabolism as a major contributor of tumor initiation, growth and metastatic dissemination in CRC. We summarize the metabolic pathways governing stem cell fate in the intestine, the metabolic adaptations of proliferating colon cancer cells and their crosstalk with oncogenic signaling, and how they fulfill the energetic demands imposed by the metastatic cascade. Lastly, we discuss how some of these metabolic pathways could represent new vulnerabilities of CRC cells with the potential to be targeted.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Intestinal stem cells; Metabolic therapies; Metabolism; Metastasis

Mesh:

Year:  2019        PMID: 31129171     DOI: 10.1016/j.semcdb.2019.05.018

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  58 in total

1.  Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

Authors:  Jeremiah Bernier-Latmani; Christophe Cisarovsky; Samantha Mahfoud; Simone Ragusa; Isabelle Dupanloup; David Barras; François Renevey; Sina Nassiri; Pascale Anderle; Mario Leonardo Squadrito; Stefanie Siegert; Suzel Davanture; Alejandra González-Loyola; Nadine Fournier; Sanjiv A Luther; Rui Benedito; Philippe Valet; Bin Zhou; Michele De Palma; Mauro Delorenzi; Christine Sempoux; Tatiana V Petrova
Journal:  Nat Cardiovasc Res       Date:  2022-05-16

2.  Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.

Authors:  Junfei Gu; Ruolan Sun; Decai Tang; Fuyan Liu; Xiangwei Chang; Qiaohan Wang
Journal:  Cell Biol Toxicol       Date:  2022-01-24       Impact factor: 6.819

Review 3.  Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex.

Authors:  Y Taank; N Agnihotri
Journal:  Clin Transl Oncol       Date:  2021-08-23       Impact factor: 3.405

4.  Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models.

Authors:  Puzi Jiang; Sicheng Wu; Qibin Luo; Xing-Ming Zhao; Wei-Hua Chen
Journal:  mSystems       Date:  2021-05-04       Impact factor: 6.496

5.  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.

Authors:  Michaela Kripnerová; Hamendra Singh Parmar; Jiří Šána; Alena Kopková; Lenka Radová; Sieghart Sopper; Krzysztof Biernacki; Jan Jedlička; Michaela Kohoutová; Jitka Kuncová; Jan Peychl; Emil Rudolf; Miroslav Červinka; Zbyněk Houdek; Pavel Dvořák; Kateřina Houfková; Martin Pešta; Zdeněk Tůma; Martina Dolejšová; Filip Tichánek; Václav Babuška; Martin Leba; Ondřej Slabý; Jiří Hatina
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

6.  A Novel N-Sulfonylamidine-Based Derivative Inhibits Proliferation, Migration, and Invasion in Human Colorectal Cancer Cells by Suppressing Wnt/β-Catenin Signaling Pathway.

Authors:  Xingming Zhao; Zhuo Han; Jiahui Ma; Shiqing Jiang; Xia Li
Journal:  Pharmaceutics       Date:  2021-05-03       Impact factor: 6.321

Review 7.  Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.

Authors:  Miljana Nenkov; Yunxia Ma; Nikolaus Gaßler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

8.  Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis.

Authors:  Suresh Chava; Suresh Bugide; Yvonne J K Edwards; Romi Gupta
Journal:  Oncogenesis       Date:  2021-07-12       Impact factor: 7.485

9.  Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.

Authors:  Dagui Lin; Wenhua Fan; Rongxin Zhang; Enen Zhao; Pansong Li; Wenhao Zhou; Jianhong Peng; Liren Li
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

Review 10.  Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery.

Authors:  Qiang Sun; Man He; Meng Zhang; Sha Zeng; Li Chen; Hui Zhao; Han Yang; Maolun Liu; Shan Ren; Haibo Xu
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.